Records containing: Influenza
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-02-13Lottery Incentive Nudges to Increase Influenza Vaccinations
-
CLINICAL_TRIALS study record update · 2023-02-03Evaluation of Psychometric Testing Properties of Severity Symptom Grading Scale of Influenza Infection: Flu-PRO Stage III
-
CLINICAL_TRIALS study record update · 2023-01-30A Phase 2b Double-blind, Randomized, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of Norketotifen (NKT) in the Treatment of Acute Uncomplicated Influenza-like Illness (ILI)
-
CLINICAL_TRIALS study record update · 2023-01-12Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake
-
CLINICAL_TRIALS study record update · 2023-01-05Arsenic and Immune Response to Influenza Vaccination in Pregnant Women and Newborns
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-12-21A Phase 1/2, Randomized, Observer-Blinded, Active-Controlled Trials to Evaluate the Safety and Immunogenicity of a Recombinant Trivalent Nanoparticle Influenza Vaccine With Matrix-M1 Adjuvant (NanoFlu) in Healthy Older Adults
-
CLINICAL_TRIALS study record update · 2022-12-16Effect of One-week vs Two-week Discontinuation of Methotrexate on Efficacy of Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis: A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2022-12-15The Epidemiology, Management, and the Associated Burden of Mental Health, Atopic and Autoimmune Conditions, and Common Infections in Alopecia Areata
-
CLINICAL_TRIALS study record update · 2022-12-05Nudging Flu Vaccination in Patients at Moderately High Risk for Flu and Flu-related Complications
-
CLINICAL_TRIALS study record update · 2022-11-17Proof of Concept Trial of Adjuvant Activity of SWE, a Squalene-based -Oil-in-water Emulsion
-
CLINICAL_TRIALS study record update · 2022-11-10Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort Study
-
CLINICAL_TRIALS study record update · 2022-11-09Safety of a Single Dose (Participants Aged 9 Years and Older) or Two Doses Given 28 Days Apart (Participants Aged 6 Months to 8 Years) of the Shenzhen Quadrivalent Influenza Vaccine (Split Virion), Inactivated
-
CLINICAL_TRIALS study record update · 2022-11-08Multicenter, Double-blind, Comparative, Randomized Tolerability, Safety and Immunogenicity Trial of the FLU-M® Tetra Inactivated Vaccine in Volunteers Aged 60 Years and Above
-
CLINICAL_TRIALS study record update · 2022-11-07Encouraging Flu Vaccination Among High-Risk Patients Identified by a Machine-Learning Model of Flu Complication Risk
-
CLINICAL_TRIALS study record update · 2022-10-28A Single-center, Randomized, Blinded, Positive Controlled Clinical Trial to Assess the Reactogenicity and Immunogenicity of a Quadrivalent Inactivated Influenza Vaccine in Healthy Participants Aged 6-35 Months
-
CLINICAL_TRIALS study record update · 2022-10-25Patient Portal Reminder/Recall for Influenza Vaccination in a Health System- RCT 3
-
CLINICAL_TRIALS study record update · 2022-10-12A Randomized, Controlled, Multicenter Phase 4 Clinic Trial to Evaluate the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vaccine (Split Virion),Inactivated
-
CLINICAL_TRIALS study record update · 2022-10-06Phase 2 Randomized, Controlled, Human Influenza A (H1N1) Challenge Study Following Administration of an Oral H1N1 HA Adenoviral-Vector Based Seasonal Influenza Vaccine and dsRNA Adjuvant to Healthy Adult Volunteers
-
CLINICAL_TRIALS study record update · 2022-09-22A First-in-human Phase I, Single Center, Randomized, Observer-blind, Placebo-controlled Study to Evaluate the Safety and Immune Response of Increasing Doses of OVX836 Vaccine After Intramuscular (IM) or Intranasal (IN) Administrations in Healthy Subjects Aged 18-49 Years.
-
CLINICAL_TRIALS study record update · 2022-09-22A Phase 2a, Single Center, Randomized, Double-blind, Controlled Study to Evaluate the Immunogenicity and the Safety of One Dose of OVX836 Influenza Vaccine at Two Dose Levels (90 µg and 180 μg), in Comparison to Influvac TetraTM, Quadrivalent Seasonal Influenza Sub-unit Vaccine, After Intramuscular Administration in Healthy Subjects Aged 18-65 Years
-
CLINICAL_TRIALS study record update · 2022-08-25Open-Label, Randomized Phase 1b Study of the Safety & Immunogenicity of Investigational Seasonal Influenza DNA Vaccine Followed by TIV Administered Intradermally (ID) or Intramuscularly (IM) in Healthy Adults 18-70 Years
-
CLINICAL_TRIALS study record update · 2022-08-25A Phase III Double Blinded, Randomized, Controlled, Non-inferiority Trial to Evaluate the Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine, in Healthy Thai Subjects Aged 65 Years and Above
-
CLINICAL_TRIALS study record update · 2022-08-23Feasibility of Randomizing Danish Citizens Aged 65-79 Years to High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in a Pragmatic Registry-Based Setting
-
CLINICAL_TRIALS study record update · 2022-08-19Improving Vaccine Acceptance and Uptake Among Underresourced African American and Latinx Older Adults: A Multidisciplinary and Culturally Based Training Program for Minority Churches
-
CLINICAL_TRIALS study record update · 2022-08-17A Clinical Trial to Assess Immunogencity and Safety of 2 Doses of anInactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8Years